What did @its.luisanna actually say?
She posted a two-month Zepbound progress update and almost didn't. Her hesitation is worth noting: she felt her results looked "slight" compared to what she sees on TikTok. What she actually reported was losing "over 13 pounds and eight inches" in eight weeks, and she framed it not as a failure but as progress that "makes sense" for her body and her plan. No wild claims. No supplement plugs. Just numbers and context.
That kind of restraint is genuinely rare in GLP-1 content. She didn't promise anyone the same results, didn't attribute the loss to anything beyond being on a plan, and didn't dramatize the timeline. The video is essentially a personal data point delivered with unusual honesty about how social media distorts expectations.
Does the science back this up?
Yes, her results are consistent with published tirzepatide data, though she is tracking at the lower end of what clinical trials observed. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) found participants lost an average of 20.9% of body weight over 72 weeks on the highest dose of tirzepatide. Early-phase loss tends to be faster, but it varies substantially by individual.
Thirteen pounds in eight weeks works out to roughly 1.6 pounds per week. That sits within the range dietitians and obesity medicine physicians typically consider sustainable, roughly one to two pounds per week during active treatment. Faster early loss is common on GLP-1 medications, but the people posting dramatic six-week transformations are often outliers, not the average patient. Her framing of consistent over fast is actually more aligned with how clinical weight loss is measured in trials than most TikTok content acknowledges.
What did they get wrong (or right)?
She got more right than wrong here. The claim that her progress "makes sense for my body" is not medically specific, but it is not wrong either. Tirzepatide response genuinely does vary by dose, metabolic baseline, starting weight, and adherence, so individual variation is real and documented.
The one thing worth flagging is not something she said incorrectly, it is something she left implicit. Comparing yourself to TikTok weight loss content is a genuinely bad benchmark. A 2023 analysis published in PLOS ONE (Simms-Cendan et al.) found that health content on TikTok systematically overrepresents extreme outcomes. People who lose 30 pounds in six weeks post. People who lose 13 pounds in eight weeks often don't, or they feel like they have to apologize when they do. Luisanna almost didn't post this. That tells you something about the information environment she and her audience are swimming in.
What should you actually know?
GLP-1 and dual GIP/GLP-1 medications like tirzepatide (Zepbound) are not magic, and the results you see on social media are not representative samples. The SURMOUNT-1 trial used a 72-week treatment window. Two months is a fraction of that. Weight loss on these medications tends to plateau and then continue in waves, and the trajectory at eight weeks tells you very little about where someone ends up at 52 weeks.
Thirteen pounds in eight weeks is a clinically meaningful result. For context, the FDA's threshold for a weight loss intervention to be considered effective is 5% of body weight loss. Depending on her starting weight, she may already be near or past that threshold in two months. Inch loss, which she also reported, is a separate and valid metric because body composition shifts can precede scale movement. She is not behind. She is on a reasonable curve.
- Response to tirzepatide varies significantly by dose. Titration schedules affect early outcomes.
- Comparing eight-week results to peer timelines on TikTok introduces significant selection bias.
- Consistent loss over time predicts better long-term outcomes than rapid early loss followed by plateau.
Bottom line
This is one of the more honest GLP-1 progress posts you will find on TikTok. She reported real numbers, contextualized them accurately, and pushed back against the unrealistic comparison culture baked into the platform. The science supports her results as plausible and meaningful. The main thing to carry away is that her instinct to post anyway, despite feeling like her progress was "slight," is the right instinct. Her numbers are not slight. The benchmark is broken.